Cabozantinib S-malate and Hepatic impairment
Result of checking the interaction of drug Cabozantinib S-malate and disease Hepatic impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Increased exposure to cabozantinib has been observed in patients with mild to moderate hepatic impairment. It is recommended to reduce the cabozantinib dose in patients with mild or moderate hepatic impairment. The use of cabozantinib is not recommended in patients with severe hepatic impairment. It is recommended to monitor liver function and urine bilirubin tests periodically during therapy.
Generic Name: cabozantinib
Brand Name: Cabometyx, Cometriq
Synonyms: Cabozantinib
Cabozantinib S-malate - zaburzenia czynności wątroby 
Cabozantinib S-malate - insuficiência hepática 
Cabozantinib S-malate - gangguan hati 
Cabozantinib S-malate - gangguan hati 
Cabozantinib S-malate - insufficienza epatica 
Cabozantinib S-malate - insuffisance hépatique 
Cabozantinib S-malate - Leberfunktionsstörung 
Cabozantinib S-malate - deterioro hepático 
Cabozantinib S-malate - печеночная недостаточность 
Cabozantinib S-malate - karaciğer yetmezliği 
Cabozantinib S-malate - اختلال كبدي 
Cabozantinib S-malate - 肝功能不全